The Blue Pill and Big Pharma: A Dangerous Investment?

The outlook of companies tied to iconic drugs like Viagra presents a nuanced investment scenario . While the initial rise of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the expiry in key markets has introduced substantial risk . Investors are now assessing the effect of generic competition , shrinking inc

read more